However, it cannot be ruled out that other PLD-dependent pathways, such as the PLD2-Grb2 complex or MAPK signaling, might also be involved in the migration of MDA-NEO and MDA-HER2 breast cancer cells. The gene discussed is ERBB2; the disease is breast cancer.